@arobiotx.bsky.social announced positive interim results from a phase 1b study of #ABX1100 for the treatment of late-onset #PompeDisease.
Read more: https://bit.ly/3ZnOYcb
#RareDisease #LateOnsetPompeDisease #MedSky
1
1
0
0